Error loading HTML
Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact May 13, 2026
Study Finds Sustained Weight Loss Possible by Transitioning from Injectable Obesity Drugs to Daily Oral Orforglipron (ATTAIN-MAINTAIN) May 13, 2026
Weight Loss Maintained Seven Times More Effectively with Continued Maximum Dose of Tirzepatide, Study Finds May 12, 2026
